Publications by authors named "Oshita M"

Purpose: Parathyroid lipoadenomas are difficult to recognize preoperatively; hence, they may remain undetected. Difficulty in recognition is thought to be due to the adipocytes present in the tumor. This study aimed to clarify the impact of adipocytes as a component of parathyroid adenomas on ultrasound evaluation.

View Article and Find Full Text PDF

Teaching requires the incorporation of communication skills, and these potentials may affect the outcomes of the learning process. This study evaluated the quality of communication between professors and students during the process of learning Dentistry. A questionnaire was developed and applied to evaluate their perceptions about their communications in an undergraduate Dentistry course.

View Article and Find Full Text PDF

In this study, an uncooled 2D nanohole array PtSi/p-Si Schottky mid-infrared (MIR) photodetector, which is essential for on-chip Si-based low-barrier MIR detectors, is presented. Room temperature operation introduces susceptibility to thermal noise and can impact stability. Through modulation frequency and reverse bias optimization, the stability improved by 7 times at 170 Hz and -3.

View Article and Find Full Text PDF

A 45-year-old man complaining of chest and back pain due to acute aortic dissection was referred to our department. A contrast enhanced computed tomography( CT) scan showed Stanford type B aortic dissection with Kommerell diverticulum and aberrant right subclavian artery. The patient underwent antihypertensive treatment for one month.

View Article and Find Full Text PDF

Plasmonic photodetectors have received increasing attention because their detection properties can be designed by tailoring their metal structures on surfaces without using any additional components. Reconfiguration of the plasmonic resonant state in a photodetector is relevant for various applications, including investigating in situ adaptive detection property changes, depending on the situation, and performing single-pixel spectroscopy in geometrically limited regions. However, the spectral responsivity change with conventional reconfiguration methods is relatively small.

View Article and Find Full Text PDF

Aim: Alterations in microbial composition of gut microbiota due to antibiotics (ATB) may lead to resistance to immune checkpoint inhibitors (ICIs). This study aimed to assess the impact of ATB use on therapeutic response in patients with hepatocellular carcinoma (HCC) receiving atezolizumab plus bevacizumab.

Methods: This study retrospectively analyzed 105 patients with HCC treated with atezolizumab plus bevacizumab as a primary systemic therapy from prospectively-registered, multicenter, cohorts.

View Article and Find Full Text PDF

We evaluated the value of secreted glycoprotein thrombospondin-2 (TSP-2) to predict hepatocellular carcinoma (HCC) occurrence in chronic hepatitis C (CHC) patients after Hepatitis C virus (HCV) elimination by direct-acting antiviral agents (DAAs). A total of 786 CHC patients without an HCC history who achieved a sustained virological response (SVR) with DAAs were randomly assigned 2:1, with 524 patients as the derivation cohort and 262 patients as the validation cohort. Serum TSP-2 levels at the end of treatment were measured by enzyme-linked immunosorbent assay (ELISA).

View Article and Find Full Text PDF

Background And Aim: Liver function can be improved in patients with chronic hepatitis C virus (HCV) infection who achieved sustained virologic response (SVR) with direct-acting antiviral (DAA) treatment. However, to our knowledge, the impact of liver function improvement after SVR on prognosis has not been investigated.

Methods: A total of 716 patients with chronic HCV infection and compensated advanced liver fibrosis who began receiving DAA treatment between September 2014 and August 2018 in 25 Japanese hospitals and achieved SVR were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how direct-acting antiviral therapy affects the long-term health outcomes of patients with decompensated cirrhosis caused by hepatitis C virus.
  • It compared 37 patients undergoing treatment with sofosbuvir and velpatasvir (SOF/VEL) to a historical control group of 65 untreated patients, focusing on rates of liver decompensation, hospitalization, and survival.
  • Results showed that the treatment group had significantly fewer decompensated events and better survival rates over two years, but the risk of developing hepatocellular carcinoma (HCC) was still high in both groups.
View Article and Find Full Text PDF
Article Synopsis
  • Combination immunotherapy using anti-PD-L1 and anti-VEGF antibodies is the standard treatment for patients with unresectable HCC, but it doesn’t benefit all patients equally.
  • A study involving 85 HCC patients showed that high levels of cell-free DNA (cfDNA) in the blood correlate with poorer treatment responses and shorter survival outcomes.
  • Specific mutations in ctDNA, particularly in the TERT gene, can indicate worse prognosis and may help doctors assess treatment effectiveness for patients receiving this therapy.
View Article and Find Full Text PDF

Objectives: A phase 1, double-blind, placebo-controlled trial was conducted to evaluate the safety, tolerability, and exploratory efficacy of repeat monthly doses of subcutaneous (SC) casirivimab and imdevimab (CAS+IMD) in uninfected adult volunteers.

Methods: Participants were randomized (3:1) to SC CAS+IMD 1200 mg or placebo every 4 weeks for up to six doses. Primary and secondary end points evaluated safety, pharmacokinetics, and immunogenicity.

View Article and Find Full Text PDF

Aim: Hepatocellular carcinoma (HCC) after sustained virologic response (SVR) has been observed even in hepatitis C virus (HCV) patients without advanced liver fibrosis. Identifying predictors for HCC incidence in patients without advanced liver fibrosis will enable efficient post-SVR HCC surveillance. This study aimed to develop a scoring system to predict the incidence of HCC after SVR in HCV patients without advanced liver fibrosis.

View Article and Find Full Text PDF

Percutaneous devices-indwelling catheters-related infections are serious clinical incidents. It is accordingly necessary to develop anti-infective coating materials suitable for the devices for long-term effectiveness. In our research group, highly dispersible and crystalline hydroxyapatite (HAp) nanoparticles doped with metallic or halogen ions possessing antibacterial activities have been developed.

View Article and Find Full Text PDF

Four types of zinc (Zn)-doped hydroxyapatite (Zn-HAp) nanoparticles were prepared using calcium nitrate tetrahydrate as an anti-sintering agent during calcination at 600°C for 1 hr, to prevent calcination-induced aggregation. The Zn content of the nanopowders was determined at 0, 4.3, 9.

View Article and Find Full Text PDF

Background: Several factors associated with hepatocellular carcinoma (HCC) occurrence after sustained virological response (SVR) in patients with hepatitis C have been reported. However, few validation studies have been performed in the era of direct-acting anti-virals (DAAs).

Aims: To develop a prediction model for HCC occurrence after DAA-mediated SVR and validate its usefulness.

View Article and Find Full Text PDF

An 83-year-old woman with congestive heart failure due to severe mitral regurgitation was referred to our department. Because acute coronary syndrome was suspected, the patient underwent emergent coronary artery angiography, which showed 75% stenosis of segment 2 and 90% stenosis of segment 11. Subsequently, segment 11 was treated by percutaneous coronary intervention.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of ramucirumab versus sorafenib as treatments for patients with hepatocellular carcinoma (HCC) and high serum α-fetoprotein (AFP) levels (≥400 ng/ml).
  • In the analysis of 24 patients (13 on ramucirumab and 11 on sorafenib), progression-free survival (PFS) was significantly longer for those receiving ramucirumab, with median PFS of 2.7 months compared to 0.9 months for sorafenib.
  • Overall, ramucirumab demonstrated a better ability to control tumor progression in HCC patients, despite similar response rates between the two treatments.
View Article and Find Full Text PDF

Aim: The aim of the present study was to investigate the clinical course in hepatitis C virus (HCV)-positive patients with decompensated liver cirrhosis after direct-acting antivirals (DAAs) have been used for HCV infection.

Methods: This multicenter study prospectively analyzed a registered cohort composed of 73 HCV-positive patients with decompensated cirrhosis who attended our 11 institutions between January 2018 and July 2018. Prognoses, including changes in the liver reserve, hepatocellular carcinoma (HCC), decompensation events, and survival, were analyzed up to July 2020, as was the initiation of DAA treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to improve the retrieval of colonic polyps post-surgery, as traditional methods often lead to fragmenting the tissue, complicating diagnosis.
  • - Researchers introduced the "water-slider method" (WSM) to surround resected polyps with water to reduce fragmentation during retrieval, and compared its effectiveness to standard methods in a controlled trial.
  • - Results showed the WSM significantly reduced fragmentation rates for small polyps (8.2% vs. 23.8%), enabling better diagnostic accuracy, while retrieval times remained similar between the two methods.
View Article and Find Full Text PDF

Background And Aim: Whether Helicobacter pylori eradication prevents metachronous recurrence after endoscopic resection (ER) of early gastric cancer remains controversial. This multicenter retrospective study aimed to evaluate the long-term (> 5 years) effects of H. pylori eradication by stratifying patients' baseline degrees of atrophic gastritis.

View Article and Find Full Text PDF

Aim: Repeated transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (HCC) eventually leads to either deteriorated hepatic reserve or TACE refractoriness. Switching to molecular targeted agents after TACE requires preservation of hepatic reserve. This study aimed to investigate the predictive factors associated with early deterioration of hepatic reserve by repeated TACE prior to refractoriness.

View Article and Find Full Text PDF

Aim: It remains unclear how direct-acting antiviral (DAA) treatments influence hepatocellular carcinoma (HCC) recurrence and survival in comparison with interferon (IFN).

Methods: In total, 338 patients with chronic hepatitis C virus (HCV) infection and previous HCC treatments who initiated IFN (N = 88, IFN group) or DAA treatment (N = 250, DAA group) from January 2005 to November 2017 at 23 hospitals and achieved sustained virologic response (SVR) were analyzed. Cumulative HCC recurrence and survival rates were compared between the two groups using propensity score (PS) matching.

View Article and Find Full Text PDF

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a new entity adopted by the newest World Health Organization classification. It is differentiated from follicular variant papillary thyroid carcinoma (FVPTC) and regarded as non-malignant disease. Here, we compared the ultrasound findings of NIFTP (n = 40) with those of FVPTC (n = 94) and encapsulated PTC (encap-PTC) (n = 157).

View Article and Find Full Text PDF

Aim: Preserved liver function may be an important factor affecting therapeutic efficacy in hepatocellular carcinoma patients treated with lenvatinib, but not all patients can be treated while preserving liver function. This study evaluated the therapeutic efficacy of lenvatinib in patients with poor liver function with and without portal hypertension.

Methods: This prospectively registered multicenter study analyzed 93 patients treated with lenvatinib.

View Article and Find Full Text PDF